Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：207
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| Trx鼠单抗标签 | 7136 |
| BrdU单抗 | 7282 |
| HRP-BrdU单抗 | 7066 |
| GAPDH 鼠单抗 | 6917 |
| HRP-GAPDH 鼠单抗 | 7006 |
| PCNA单抗 | 7312 |
| α-tubulin 鼠单抗 | 6937 |
| β-tubulin 鼠单抗 | 7313 |
| HRP-β-tubulin 鼠单抗 | 7128 |
| β-Actin 鼠单抗 | 7311 |
| HRP-β-Actin 鼠单抗 | 7015 |
| Histone H3鼠单抗 | 7057 |
| 糖基化血红蛋白单抗 | 7278 |
| 糖基化血红蛋白抗体 | 7309 |
| C肽鼠单抗 | 6620 |
| 胰岛素鼠单抗 | 6994 |
| 胃蛋白酶原II鼠单抗 | 7073 |
| 鼠抗人胃泌素17单抗 | 6965 |
| 心肌钙蛋白鼠单抗（CTNI抗体) | 7045 |
| 肌红蛋白鼠单抗 | 7175 |